Yuka Asami

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients

Sou Hirose, Naoya Murakami, Kazuaki Takahashi et al. · Gynecologic Oncology · 2019 · 48 citations

Genomic Alterations, Cervical Cancer Management, Oncology +11

Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer

Yuka Asami, Mayumi Kobayashi Kato, Kengo Hiranuma et al. · British Journal of Cancer · 2023 · 38 citations · Full text

TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer

Ikumi Kuno, Daisuke Takayanagi, Yuka Asami et al. · Scientific Reports · 2021 · 36 citations · Full text

Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer

Mayumi Kobayashi-Kato, Erisa Fujii, Yuka Asami et al. · Gynecologic Oncology · 2023 · 35 citations

Tumoral Pathology, Medicine, Gynecology +8

Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix

Daisuke Takayanagi, Sou Hirose, Ikumi Kuno et al. · Cancers · 2021 · 32 citations · Full text